Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 19(5): e0303257, 2024.
Article in English | MEDLINE | ID: mdl-38753830

ABSTRACT

Patterns of single nucleotide polymorphisms (SNPs) in eukaryotic DNA are traditionally attributed to selective pressure, drift, identity descent, or related factors-without accounting for ways in which bias during de novo SNP formation, itself, might contribute. A functional and phenotypic analysis based on evolutionary resilience of DNA points to decreased numbers of non-synonymous SNPs in human and other genomes, with a predominant component of SNP depletion in the human gene pool caused by robust preferences during de novo SNP formation (rather than selective constraint). Ramifications of these findings are broad, belie a number of concepts regarding human evolution, and point to a novel interpretation of evolving DNA across diverse species.


Subject(s)
Evolution, Molecular , Polymorphism, Single Nucleotide , Humans , Genome, Human , Animals , Genome/genetics , Genomics/methods
2.
PLoS One ; 11(10): e0163615, 2016.
Article in English | MEDLINE | ID: mdl-27732613

ABSTRACT

Small molecules that correct the folding defects and enhance surface localization of the F508del mutation in the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) comprise an important therapeutic strategy for cystic fibrosis lung disease. However, compounds that rescue the F508del mutant protein to wild type (WT) levels have not been identified. In this report, we consider obstacles to obtaining robust and therapeutically relevant levels of F508del CFTR. For example, markedly diminished steady state amounts of F508del CFTR compared to WT CFTR are present in recombinant bronchial epithelial cell lines, even when much higher levels of mutant transcript are present. In human primary airway cells, the paucity of Band B F508del is even more pronounced, although F508del and WT mRNA concentrations are comparable. Therefore, to augment levels of "repairable" F508del CFTR and identify small molecules that then correct this pool, we developed compound library screening protocols based on automated protein detection. First, cell-based imaging measurements were used to semi-quantitatively estimate distribution of F508del CFTR by high content analysis of two-dimensional images. We evaluated ~2,000 known bioactive compounds from the NIH Roadmap Molecular Libraries Small Molecule Repository in a pilot screen and identified agents that increase the F508del protein pool. Second, we analyzed ~10,000 compounds representing diverse chemical scaffolds for effects on total CFTR expression using a multi-plate fluorescence protocol and describe compounds that promote F508del maturation. Together, our findings demonstrate proof of principle that agents identified in this fashion can augment the level of endoplasmic reticulum (ER) resident "Band B" F508del CFTR suitable for pharmacologic correction. As further evidence in support of this strategy, PYR-41-a compound that inhibits the E1 ubiquitin activating enzyme-was shown to synergistically enhance F508del rescue by C18, a small molecule corrector. Our combined results indicate that increasing the levels of ER-localized CFTR available for repair provides a novel route to correct F508del CFTR.


Subject(s)
Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , Cystic Fibrosis/pathology , Endoplasmic Reticulum/metabolism , Small Molecule Libraries/chemistry , Alleles , Benzoates/chemistry , Benzoates/pharmacology , Cells, Cultured , Cystic Fibrosis/genetics , Cystic Fibrosis Transmembrane Conductance Regulator/chemistry , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Furans/chemistry , Furans/pharmacology , Gene Deletion , HEK293 Cells , HeLa Cells , High-Throughput Screening Assays , Humans , Hydroxamic Acids/chemistry , Hydroxamic Acids/pharmacology , Microscopy, Fluorescence , Protein Folding , Protein Structure, Tertiary , Pyrazoles/chemistry , Pyrazoles/pharmacology , RNA, Messenger/metabolism , Small Molecule Libraries/pharmacology , Ubiquitination/drug effects , Vorinostat
3.
Genome Biol Evol ; 7(9): 2506-19, 2015 Aug 06.
Article in English | MEDLINE | ID: mdl-26253317

ABSTRACT

In this study, we show novel DNA motifs that promote single nucleotide polymorphism (SNP) formation and are conserved among exons, introns, and intergenic DNA from mice (Sanger Mouse Genomes Project), human genes (1000 Genomes), and tumor-specific somatic mutations (data from TCGA). We further characterize SNPs likely to be very recent in origin (i.e., formed in otherwise congenic mice) and show enrichment for both synonymous and parallel DNA variants occurring under circumstances not attributable to purifying selection. The findings provide insight regarding SNP contextual bias and eukaryotic codon usage as strategies that favor long-term exonic stability. The study also furnishes new information concerning rates of murine genomic evolution and features of DNA mutagenesis (at the time of SNP formation) that should be viewed as "adaptive."


Subject(s)
Evolution, Molecular , Mice/genetics , Polymorphism, Single Nucleotide , Animals , Artifacts , Codon , DNA, Complementary/chemistry , Exons , Genome , Heterozygote , High-Throughput Nucleotide Sequencing , Humans , Mutation , Neoplasms/genetics , Nucleotide Motifs
4.
PLoS One ; 9(10): e109186, 2014.
Article in English | MEDLINE | ID: mdl-25350658

ABSTRACT

Like many other ancient genes, the cystic fibrosis transmembrane conductance regulator (CFTR) has survived for hundreds of millions of years. In this report, we consider whether such prodigious longevity of an individual gene--as opposed to an entire genome or species--should be considered surprising in the face of eons of relentless DNA replication errors, mutagenesis, and other causes of sequence polymorphism. The conventions that modern human SNP patterns result either from purifying selection or random (neutral) drift were not well supported, since extant models account rather poorly for the known plasticity and function (or the established SNP distributions) found in a multitude of genes such as CFTR. Instead, our analysis can be taken as a polemic indicating that SNPs in CFTR and many other mammalian genes may have been generated--and continue to accrue--in a fundamentally more organized manner than would otherwise have been expected. The resulting viewpoint contradicts earlier claims of 'directional' or 'intelligent design-type' SNP formation, and has important implications regarding the pace of DNA adaptation, the genesis of conserved non-coding DNA, and the extent to which eukaryotic SNP formation should be viewed as adaptive.


Subject(s)
Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Evolution, Molecular , Hominidae/genetics , Polymorphism, Single Nucleotide , Alleles , Animals , Cystic Fibrosis/genetics , Exons , Founder Effect , Gene Frequency , Humans , Introns , Mutation , Selection, Genetic , White People , Y Chromosome
SELECTION OF CITATIONS
SEARCH DETAIL
...